Injectable HIV prevention drug shows promise: we worked out how much South Africa should pay for it

By Lise Jamieson, Senior Researcher, University of the Witwatersrand
Gesine Meyer-Rath, Research associate professor in Global Health, Boston University

Pre-exposure prophylaxis (PrEP) is an HIV prevention method. It is taken by people who are HIV negative, so that if they are unknowingly exposed to HIV, the drug will prevent the virus from infecting them.

The development of this method is important for South Africa because the country is the epicentre of the HIV pandemic. Around 7.5 million people in South Africa live with HIV – about a fifth of the global population of people living with HIV.

The current standard-of-care PrEP…

Read complete article

~	Hate Speech: Turning the tide

~	Streaming platforms will soon be required to invest more in Australian TV and films, which could be good news for our screen sector

~	My kid is biting, hitting and kicking. I’m at my wit’s end, what can I do?

~	Myanmar: Two years after coup, global action needed to halt military’s ‘nationwide assault on human rights’

~	'Discriminatory impact on First Nations people': coroner calls for urgent bail reform in Veronica Nelson inquest

~	What's driving the potato chip shortage and when will it pass?

~	New Zealand's tax system is under the spotlight (again). What needs to change to make it fair?

~	What makes archaeology useful as well as exciting? It offers lessons from the past

~	Children and teens aren't doing enough physical activity - new study sounds a health warning

~	It’s hot, and your local river looks enticing. But is too germy for swimming?